Drimva

GSK

Medical Director, Oncology Clinical Development - Lung & Head/Neck Cancers

$223K–$371K

USA - Pennsylvania - Upper Providence +5 · Hybrid (Remote & On-site) · Director · Full-time · Posted Oct 20, 2026

Location
USA - Pennsylvania - Upper Providence
USA - Massachusetts - Waltham
UK - Hertfordshire - Stevenage
Switzerland - Zug
UK – London – New Oxford Street
Canada - Ontario - Mississauga - Milverton Drive
Education
MD (or equivalent medical degree)

About the job

Provides physician leadership for lung and head/neck cancer clinical studies, overseeing medical monitoring and safety, interpreting data, and contributing to study design and delivery.

What you'll do

  • Lead medical monitoring and safety oversight, including review of trial data and benefit–risk assessment.
  • Contribute medical expertise to study protocols, data interpretation, regulatory interactions, and scientific communications.
  • Collaborate with cross-functional teams, investigators, and external experts on clinical study execution.

What they ask for

  • MD (or equivalent medical degree) and board certification or eligibility in oncology, haematology, or a related specialty.
  • Clinical experience in oncology and/or relevant therapeutic areas, with direct exposure to clinical research or drug development.
  • Experience in clinical trial conduct, including medical monitoring, safety review, and clinical data interpretation.
  • Experience applying clinical judgement to study design and patient safety, working in cross-functional teams, and translating clinical data into clear insights.

Nice to have

  • Experience in pharmaceutical or biotechnology development across Phase I–III Lung & Head/Neck oncology studies.
  • Knowledge of GCP, ICH guidelines, and global regulatory frameworks; experience with regulatory interactions is also valued.

Pay

USD 222,750 to USD 371,250 (annual base salary)

Tools

GCP, ICH guidelines, real-world evidence, AI-enabled insights

AI focus

Familiarity with AI-enabled insights as an emerging data and analytics approach to support clinical interpretation and decision-making is preferred.

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 6, 2026 (UTC)